These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 1683290

  • 1. Low doses of l-sulpiride down-regulate striatal and cortical dopamine receptors and beta-adrenoceptors.
    Sigala S, Rizzonelli P, Zanelli E, Forgione A, Missale C, Spano P.
    Eur J Pharmacol; 1991 Jun 25; 199(2):247-53. PubMed ID: 1683290
    [Abstract] [Full Text] [Related]

  • 2. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL, Rose S, Jenner P, Marsden CD.
    Biochem Pharmacol; 1992 Jul 07; 44(1):83-91. PubMed ID: 1321631
    [Abstract] [Full Text] [Related]

  • 3. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
    Singh NA, Bush LG, Gibb JW, Hanson GR.
    Brain Res; 1992 Feb 07; 571(2):260-4. PubMed ID: 1351780
    [Abstract] [Full Text] [Related]

  • 4. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P, Olianas MC, Gessa GL.
    Mol Pharmacol; 1985 Aug 07; 28(2):138-45. PubMed ID: 2410769
    [Abstract] [Full Text] [Related]

  • 5. Castration blocks chronic sulpiride-induced desensitization of striatal D1 receptor-stimulated adenylate cyclase activity in male rats.
    Ryan-Jastrow T, Gnegy ME.
    J Pharmacol Exp Ther; 1989 Feb 07; 248(2):626-31. PubMed ID: 2521900
    [Abstract] [Full Text] [Related]

  • 6. Repeated administration of (-)sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions.
    Memo M, Pizzi M, Nisoli E, Missale C, Carruba MO, Spano P.
    Eur J Pharmacol; 1987 Jun 12; 138(1):45-51. PubMed ID: 2887436
    [Abstract] [Full Text] [Related]

  • 7. Characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the frontal cerebral cortex of the rat. Comparative effects of neuroleptics on frontal cortex and striatal dopamine sensitive adenylate cyclases.
    Bockaert J, Tassin JP, Thierry AM, Glowinski J, Premont J.
    Brain Res; 1977 Feb 11; 122(1):71-86. PubMed ID: 837225
    [Abstract] [Full Text] [Related]

  • 8. Supersensitivity of striatal D2 dopamine receptors mediating inhibition of adenylate cyclase and stimulation of guanosine triphosphatase following chronic administration of haloperidol in mice.
    Olianas MC, Onali P.
    Neurosci Lett; 1987 Aug 05; 78(3):349-54. PubMed ID: 2819791
    [Abstract] [Full Text] [Related]

  • 9. mu-Opioid receptor-regulated adenylate cyclase activity in primary cultures of rat striatal neurons upon chronic morphine exposure.
    Van Vliet BJ, De Vries TJ, Wardeh G, Mulder AH, Schoffelmeer AN.
    Eur J Pharmacol; 1991 Oct 14; 208(2):105-11. PubMed ID: 1666051
    [Abstract] [Full Text] [Related]

  • 10. Sulpiride and the role of dopaminergic receptor blockade in the antipsychotic activity of neuroleptics.
    Memo M, Battaini F, Spano PF, Trabucchi M.
    Acta Psychiatr Scand; 1981 Apr 14; 63(4):314-24. PubMed ID: 7315480
    [Abstract] [Full Text] [Related]

  • 11. On the mechanism of neuroleptic induced increase in striatal dopamine release: brain dialysis provides direct evidence for mediation by autoreceptors localized on nerve terminals.
    Westerink BH, de Vries JB.
    Neurosci Lett; 1989 Apr 24; 99(1-2):197-202. PubMed ID: 2526308
    [Abstract] [Full Text] [Related]

  • 12. Evidence for the presence of both D-1 and D-2 dopamine receptors in human esophagus.
    Missale G, Missale C, Sigala S, Cestari R, Memo M, Lojacono L, Spano P.
    Life Sci; 1990 Apr 24; 47(5):447-55. PubMed ID: 1697642
    [Abstract] [Full Text] [Related]

  • 13. Repeated administration of lisuride down-regulates dopamine D-2 receptor function in mesostriatal and in mesolimbocortical rat brain regions.
    Nisoli E, Memo M, Missale C, Carruba MO, Spano PF.
    Eur J Pharmacol; 1990 Jan 25; 176(1):85-90. PubMed ID: 1968845
    [Abstract] [Full Text] [Related]

  • 14. Pharmacological characterization of D1 and D2 dopamine receptors in rat limbocortical areas. I. Frontal cortex.
    Nisoli E, Grilli M, Memo M, Missale C, Spano PF.
    Neurosci Lett; 1988 May 03; 87(3):247-52. PubMed ID: 2898117
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Tolerance to hypoactivity and sensitization to hyperactivity after chronic treatment with a presynaptic dose of lisuride in rats.
    Nisoli E, Tonello C, Memo M, Pizzi M, Spano P, Reina G, Carruba MO.
    Eur J Pharmacol; 1992 May 27; 216(1):81-6. PubMed ID: 1356088
    [Abstract] [Full Text] [Related]

  • 19. Inhibitory influence of the mesocortical dopaminergic neurons on their target cells: electrophysiological and pharmacological characterization.
    Godbout R, Mantz J, Pirot S, Glowinski J, Thierry AM.
    J Pharmacol Exp Ther; 1991 Aug 27; 258(2):728-38. PubMed ID: 1865369
    [Abstract] [Full Text] [Related]

  • 20. Characterization of sulpiride-displaceable 3H-YM-09151-2 binding sites in rat frontal cortex and the effects of subchronic treatment with haloperidol on cortical D-2 dopamine receptors.
    Kazawa T, Mikuni M, Higuchi T, Arai I, Takahashi K, Yamauchi T.
    Life Sci; 1990 Aug 27; 47(6):531-7. PubMed ID: 2402179
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.